{
    "organizations": [],
    "uuid": "cf9a8d45c88b9483ed991af863e1ae18dcf97747",
    "author": "",
    "url": "https://www.reuters.com/article/brief-22nd-century-ceo-henry-sicignano-t/brief-22nd-century-ceo-henry-sicignano-to-discuss-fdas-nicotine-reduction-plan-with-institutional-investors-idUSFWN1R10QE",
    "ord_in_thread": 0,
    "title": "BRIEF-22nd Century ‍CEO Henry Sicignano To Discuss FDA's Nicotine Reduction Plan With Institutional Investors",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 19, 2018 / 1:31 PM / Updated 24 minutes ago BRIEF-22nd Century ‍CEO Henry Sicignano To Discuss FDA's Nicotine Reduction Plan With Institutional Investors Reuters Staff 1 Min Read March 19 (Reuters) - 22Nd Century Group Inc: * 22ND CENTURY - CO’S ‍CEO HENRY SICIGNANO III​ TO DISCUSS FDA’S NICOTINE REDUCTION PLAN WITH INSTITUTIONAL INVESTORS IN NEW YORK, CHICAGO AND BOSTON Source text for Eikon: Further company coverage:",
    "published": "2018-03-19T15:29:00.000+02:00",
    "crawled": "2018-03-19T15:52:10.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "century",
        "henry",
        "sicignano",
        "discus",
        "fda",
        "nicotine",
        "reduction",
        "plan",
        "institutional",
        "investor",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "22nd",
        "century",
        "group",
        "inc",
        "22nd",
        "century",
        "co",
        "henry",
        "sicignano",
        "discus",
        "fda",
        "nicotine",
        "reduction",
        "plan",
        "institutional",
        "investor",
        "new",
        "york",
        "chicago",
        "boston",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}